InBody Co.,Ltd (KOSDAQ:041830)

South Korea flag South Korea · Delayed Price · Currency is KRW
41,350
+3,700 (9.83%)
Jun 9, 2026, 3:30 PM KST
Market Cap551.53B +82.2%
Revenue (ttm)246.81B +16.6%
Net Income39.96B +27.5%
EPS3,116.16 +27.8%
Shares Out 13.34M
PE Ratio13.27
Forward PE11.41
Dividend400.00 (1.06%)
Ex-Dividend DateMar 30, 2026
Volume89,138
Open38,050
Previous Close37,650
Day's Range38,050 - 41,450
52-Week Range22,850 - 48,900
Beta0.70
Analystsn/a
Price Targetn/a
Earnings DateAug 11, 2026

About InBody Co.,Ltd

InBody Co.,Ltd provides body composition analysis solutions worldwide. It offers body composition analyzers, automatic blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 1996
Employees 342
Stock Exchange KOSDAQ
Ticker Symbol 041830
Full Company Profile

Financial Performance

In 2025, InBody Co.,Ltd's revenue was 233.95 billion, an increase of 14.42% compared to the previous year's 204.46 billion. Earnings were 30.63 billion, a decrease of -7.57%.

Financial Statements